Application | Comment | Organism |
---|---|---|
medicine | Trypanosoma cruzi is the causative agent of Chagas' disease, enzyme is a good target for the development of new anti-chagasic drugs | Trypanosoma cruzi |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli | Trypanosoma cruzi |
Crystallization (Comment) | Organism |
---|---|
sitting drop vapour diffusion, primitive orthorhombic crystals, space group P2(1)2(1)2(1), a : 65.97 A, b : 107.61 A, c : 179.08 A | Trypanosoma cruzi |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + oxaloacetate | Trypanosoma cruzi | - |
ADP + phosphoenolpyruvate + CO2 | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Trypanosoma cruzi | P51058 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Trypanosoma cruzi |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + oxaloacetate | - |
Trypanosoma cruzi | ADP + phosphoenolpyruvate + CO2 | - |
r |
Subunits | Comment | Organism |
---|---|---|
dimer | - |
Trypanosoma cruzi |
Synonyms | Comment | Organism |
---|---|---|
ATP:oxaloacetate carboxylyase (transphosphorylating) | - |
Trypanosoma cruzi |
PEPCK | - |
Trypanosoma cruzi |
phosphoenolpyruvate carboxykinase | - |
Trypanosoma cruzi |